Talimogene Laherparepvec (T-VEC) (lmlygic) is an FDA-approved oncolytic virus therapy made from a modified herpes virus, more commonly known for causing cold sores. T-VEC is injected directly into the lesion to cause cancer cells to die.
It’s approved for melanoma that cannot be surgically removed, including stage IIIB, IIIC, and IV. Your doctor will use a needle to inject the medication directly into the tumor, often every 2 to 3 weeks over a period of time. This is dependent on the number and size of your tumors, as well as your response to treatment.Read More
- Stomach discomfort or nausea
- Flu-like symptoms
- Pain at the injection site
- Extreme fatigue
- Eye pain and/or sensitivity to light